Nodular Sclerosis is the Most Common Subtype of Classical Hodgkin Lymphoma
Nodular sclerosis (NS) is the most common histologic subtype of classical Hodgkin lymphoma, accounting for approximately 60-70% of cases. 1, 2, 3
Classification of Classical Hodgkin Lymphoma
Classical Hodgkin lymphoma (cHL) comprises 95% of all Hodgkin lymphoma cases and includes four distinct histologic subtypes 1, 2:
- Nodular sclerosis (NS) - most common
- Mixed cellularity (MC) - second most common
- Lymphocyte-rich (LR) - less common
- Lymphocyte-depleted (LD) - least common
The remaining 5% of Hodgkin lymphoma cases consist of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), which is a distinct entity with different immunophenotype and clinical behavior 1, 3.
Clinical Significance of Nodular Sclerosis Subtype
The nodular sclerosis subtype is particularly common in young adults and frequently presents with mediastinal involvement. 4 Recent data from a large Indonesian tertiary hospital study confirmed that NS accounted for 62.38% of 739 classical Hodgkin lymphoma cases over a decade, with significant association with early-stage disease (stages I-III) 5.
Key Features of Nodular Sclerosis:
- Most commonly affects the anterior mediastinum and mediastinal lymph nodes 4
- Typically presents in young women 4
- Characterized histologically by nodules of polymorphous inflammatory cells surrounded by broad fibrous bands 4
- Contains variable numbers of Hodgkin/Reed-Sternberg cells required for diagnosis 4
Important Clinical Caveat
While the morphological subtype classification is important for accurate diagnosis, it does not influence treatment decisions in classical Hodgkin lymphoma. 6 All subtypes of cHL are treated according to stage and risk factors rather than histologic subtype. The critical distinction is between classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma, as the latter may require different treatment approaches including anti-CD20 antibody therapy 7.
The immunophenotype remains essential for diagnosis: classical Hodgkin lymphoma (including NS) characteristically shows CD30+/CD15+ positivity in Hodgkin-Reed-Sternberg cells, distinguishing it from NLPHL which shows CD20+/CD45+ but lacks CD15 and CD30 3, 8.